Examine the evolution of Qiagen's (QGEN) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.

Explore how Snap's (SNAP) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.

Examine DNOW's (DNOW) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.

Explore Krispy Kreme's (DNUT) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

Explore CSG Systems' (CSGS) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

Evaluate Haemonetics' (HAE) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.

Credo Technology's 79% YTD surge is fueled by AI-driven demand, but premium valuation and hyperscaler risks cloud the near-term outlook.

Merck slips following its Q2 results as Gardasil sales slump. However, Keytruda, new launches and a rich pipeline bolster its long-term case.

F delays its next-gen EV truck and van to 2028, betting that smaller, cheaper models will drive long-term profitability.

AMC Entertainment, the largest U.S. and global theater chain, saw its finances improve in the June quarter and its stock pop Monday as CEO Adam Aron cited a recovering box office industry-wide and stronger numbers across AMC and Odeon in Europe. Revenues rose 35% to $1.4 billion Net loss narrowed to $4.7 million from $32.

NuScale Power's NYSE: SMR stock price is heading for an atomic-sized surge, driven by its market position, accelerated timeline to operations, and market dynamics. The company's position is unparalleled; it is the only one with U.S. Nuclear Regulatory Commission design approval and on track to deploy its first commercial reactors within a few years.

Dole plc (NYSE:DOLE ) Q2 2025 Earnings Call August 11, 2025 8:00 AM ET Company Participants Jacinta F. Devine - CFO & Director James O'Regan - Head of Investor Relations Rory Patrick Byrne - CEO & Executive Director Conference Call Participants Christopher Jayaseelan Barnes - Deutsche Bank AG, Research Division Gary Martin - Davy, Research Division Peter Thomas Galbo - BofA Securities, Research Division Operator Welcome to Dole plc's Second Quarter 2025 Earnings Conference Call and Webcast.

I invest for long-term total return, prioritizing dividend growth and quality companies trading at bargain valuations, especially during industry downturns. Despite current headwinds like tariffs and patent expirations, I see long-term opportunity in top-tier pharmaceutical stocks due to strong fundamentals and future AI benefits. My quantitative screen highlights six pharma leaders, with Novo Nordisk (NVO) and Merck (MRK) scoring highest across dividends, growth, capital structure, and free cash flow.

Neils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting experience working for news organizations throughout Canada. His experiences include covering territorial and federal politics in Nunavut, Canada.

APA tops Q2 forecasts with stronger production, cost cuts. and shareholder returns despite softer oil prices.

Pfizer posts strong Q2 earnings and raises EPS outlook, with oncology growth and new drugs offsetting looming headwinds.

Does Robinhood's rapid expansion, soaring stock gains and higher earnings outlook give it the edge over Tradeweb in the fintech race? Let's find out.

Evaluate the expected performance of Advance Auto Parts (AAP) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Nice (NICE), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.

Besides Wall Street's top-and-bottom-line estimates for Amcor (AMCR), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.